Basecamp Wealth Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16
Closed -$269 1857
2026
Q1
$269 Sell
16
-151
-90% -$2.7K ﹤0.01% 1834
2025
Q4
$2.68K Buy
+167
New +$2.49K ﹤0.01% 1292

Other funds holding CLB

Basecamp Wealth Advisors's CLB Position: Q2 2026 in Review

Basecamp Wealth Advisors sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 16 shares — an estimated $269 sold.

Basecamp Wealth Advisors first reported a position in CLB in Q4 2025 and held it in 2 quarters. The position peaked at $2.68K in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Basecamp Wealth Advisors reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Basecamp Wealth Advisors sold 16 Core Laboratories shares in Q2 2026, an estimated $269.
  • Basecamp Wealth Advisors first reported a position in Core Laboratories in Q4 2025 and held it in 2 quarters.
  • Basecamp Wealth Advisors's Core Laboratories position peaked at $2.68K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.